Eric Van Alstyne is currently the Sr. Director of Corporate Development at Molex, a role they have held since 2023 after progressing from Director and Manager positions within the same department. They serve on the boards of Eideticom and ECL, and as a board observer for Windgap Medical, Inc. and Aerami Therapeutics. Prior to their current roles, Eric gained experience as an Investment Banking Analyst at Citi and as a Summer Analyst at Jefferies LLC. Eric holds a Bachelor of Business Administration from the University of Michigan - Stephen M. Ross School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices